The estimated Net Worth of Chetan Shah is at least $62.9 Thousand dollars as of 17 December 2020. Chetan Shah owns over 26,852 units of Aethlon Medical Inc stock worth over $6,274 and over the last 11 years he sold AEMD stock worth over $56,658. In addition, he makes $0 as Independent Director at Aethlon Medical Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Chetan Shah AEMD stock SEC Form 4 insiders trading
Chetan has made over 1 trades of the Aethlon Medical Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 26,852 units of AEMD stock worth $56,658 on 17 December 2020.
The largest trade he's ever made was selling 26,852 units of Aethlon Medical Inc stock on 17 December 2020 worth over $56,658. On average, Chetan trades about 746 units every 0 days since 2014. As of 17 December 2020 he still owns at least 16,641 units of Aethlon Medical Inc stock.
You can see the complete history of Chetan Shah stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Chetan Shah biography
Dr. Chetan S. Shah M.D. serves as Independent Director of the Company. Dr. Shah has served as a director of the Company since June 2013. Dr. Shah is a board certified Otolaryngologist. He is a partner and Board member of the Surgery Center at Hamilton, as well as Physician Management Systems and Princeton Eye & Ear, which he founded in 2009. Dr. Shah serves on the Board of one other private company. He holds teaching positions and serves on multiple hospital committees in the area and is on the Audiology and Speech Language Pathology Committee for the State of New Jersey. Dr. Shah also was a member of the Board of Medical Examiners for the State of New Jersey. Dr. Shah received his Bachelor’s degree and Medical Degree from Rutgers University and Robert Wood Johnson Medical School. Shah is qualified to serve as our director because of his medical background as both a board certified Otolaryngologist and a member of various medical boards and hospital committees in New Jersey.
How old is Chetan Shah?
Chetan Shah is 51, he's been the Independent Director of Aethlon Medical Inc since 2013. There are 7 older and 1 younger executives at Aethlon Medical Inc. The oldest executive at Aethlon Medical Inc is Edward Broenniman, 84, who is the Chairman of the Board.
What's Chetan Shah's mailing address?
Chetan's mailing address filed with the SEC is 11555 SORRENTO VALLEY ROAD, SUITE 203, , SAN DIEGO, CA, 92121.
Insiders trading at Aethlon Medical Inc
Over the last 11 years, insiders at Aethlon Medical Inc have traded over $56,658 worth of Aethlon Medical Inc stock. The most active insiders traders include James A Joyce, Angela Rossetti, and Chetan Shah. On average, Aethlon Medical Inc executives and independent directors trade stock every 56 days with the average trade being worth of $4,427. The most recent stock trade was executed by Chetan Shah on 17 December 2020, trading 26,852 units of AEMD stock currently worth $56,658.
What does Aethlon Medical Inc do?
the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.
What does Aethlon Medical Inc's logo look like?
Complete history of Chetan Shah stock trades at Aethlon Medical Inc
Aethlon Medical Inc executives and stock owners
Aethlon Medical Inc executives and other stock owners filed with the SEC include:
-
Steven P. Larosa M.D.,
Chief Medical Officer & Acting Chief Scientific Officer -
Dr. Charles J. Fisher Jr., M.D.,
CEO, Director & Member of Extracorporeal Therapy Advisory Board -
James B. Frakes M.B.A.,
CFO, Sr. VP of Fin. & Sec. -
James Frakes,
Chief Financial Officer, Senior Vice President - Finance, Secretary -
Charles Fisher,
Chief Executive Officer -
Guy F. Cipriani BS (Eng.), MBA,
Sr. VP, Chief Bus. Officer & Director -
Chetan Shah,
Independent Director -
Sabrina Johnson,
Independent Director -
Guy Cipriani,
Independent Director -
Edward Broenniman,
Chairman of the Board -
Dr. Richard H. Tullis,
Consultant -
Sunil Sawhney,
Head of Clinical Studies -
Rodney S Kenley,
President -
Timothy C Jr Rodell,
Chief Executive Officer -
Franklyn S Jr Barry,
Director -
Richard Tullis,
VP, CHIEF SCIENCE OFFICER -
Phillip A Ward,
Director -
James A Joyce,
Chairman, CEO, Secretary -
Nicolas Gikakis,
-
Steven P Larosa,
Chief Medical Officer -
Angela Rossetti,
-
Lee D Arnold,
Chief Scientific Officer